Flexion Therapeutics, Inc.
FLUTICASONE EXTENDED-RELEASE FORMULATIONS AND METHODS OF USE THEREOF
Last updated:
Abstract:
This disclosure relates to extended-release fluticasone propionate (FP) formulations that include small microparticles and/or nanoparticles and methods of using these extended-release FP formulations for treating pain and/or inflammation in a subject.
Status:
Application
Type:
Utility
Filling date:
16 Mar 2018
Issue date:
9 Jan 2020